300015.SZ Decision Brief — research Aier Eye Hospital before you trade it

Business quality of Aier Eye Hospital: —/100

The latest scan has no quality score for 300015.SZ yet — run the live brief to complete the full checklist free.

Important: this score measures business quality only, not whether today's price is fair. A 90+ quality stock can still be expensive enough to be a bad deal, and a 40-quality stock can be cheap enough to compensate you for the risk. That separation is exactly why the workflow treats quality and price as two different questions that only meet at the valuation ceiling.

The valuation ceiling: the price you shouldn't pay past

Working value analysis doesn't ask "will Aier Eye Hospital grow?" It asks "what does ¥8.52 already assume?" Our two-stage residual-income model turns those assumptions into a single ceiling number. Below the ceiling you are paying a discount; above it you are paying for hope. Neither is automatically wrong — the point is knowing which one you're doing.

Run 300015.SZ's numbers yourself at the free Berkshire intrinsic value calculator — every input is documented, and you can adjust each assumption to match your own view.

How to read the WAIT signal on 300015.SZ

• Status: WAIT — no clear trend boundary yet. "No opinion" is itself a disciplined opinion.
• Age: 31 bars — a relatively fresh signal — the original reason is likely still standing.
• uPnL +0.0% · total return -33.6% — cumulative performance of the signal inside our system. It measures how the engine has behaved historically, not a forecast for you.

The right order: quality passes first → the ceiling is acceptable → thesis breaks are written down → then look at the signal. Looking at the signal first and hunting for reasons afterward is confirmation bias, and it gets everyone.

What would break the Aier Eye Hospital thesis (a template for Healthcare Svcs)

Before investing real money, write your own break-conditions down. Common templates analysts use for Healthcare Svcs names:

1. The flagship drug/device loses exclusivity or loses share to generics
2. A pivotal trial fails beyond the timeline the price assumes
3. Government pricing or industry-tax policy shifts
4. A major consolidation changes payer bargaining power

The point is not the list above — it's that you write yours before buying. Conditions written while you own nothing are always colder than conditions written while you are down.

Terms used on this page

• Quality score — a 0-100 rule-based Berkshire-style checklist grade (earnings consistency, debt structure, cash conversion). 300015.SZ: — as of scan 2026-08-27.
• Valuation ceiling — the highest price your thesis can pay without underpaying for risk, computed with a documented two-stage residual-income model.
• Signal / Side — the timing engine's status as of the snapshot: LONG, SHORT, or WAIT. 300015.SZ: WAIT.
• uPnL — unrealized profit/loss accumulated by an open signal, measured from its entry price. Not your personal return.
• Age (bars) — price bars since the signal started. 300015.SZ: 31.
• Thesis break — a measurable event that should change your mind. Written before you buy, not after.